Ellis Neufeld

Dr. Ellis Neufeld earned his Bachelor’s degree in Chemistry and Biology from Wesleyan University in Connecticut and received his MD and PhD degrees from Washington University in St. Louis. Dr. Neufeld was an intern and resident in pediatrics at Boston Children’s, before completing fellowships there in Clinical Genetics, and in Hematology/Oncology. Dr. Neufeld’s laboratory interest has been in elucidation of genes responsible for inherited blood disorders. His clinical research activities include observational studies such as the ATHN-2 switching study launched in 2015, and interventional trials in hemophilia, thalassemia and ITP. He is presently Associate Chief of the Dana-Farber-Boston Children’s Cancer and Blood Disorders Center, and he is the Egan Family Foundation Professor of Transitional Medicine at Harvard Medical School. He serves as Medical Director for the Boston Hemophilia Center, a joint effort of Brigham and Women’s and Boston Children’s Hospitals. He a member of the Hemophilia Alliance Board of Directors, and he is Chair-elect of the Board of Directors of ATHN.

Back to Board Members page